Patents Assigned to PLATELET TARGETED THERAPEUTICS, LLC
  • Platelet targeted treatment
    Patent number: 10294291
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: May 21, 2019
    Assignee: PLATELET TARGETED THERAPEUTICS, LLC
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • Platelet targeted treatment
    Patent number: 9982034
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: May 29, 2018
    Assignee: PLATELET TARGETED THERAPEUTICS, LLC
    Inventors: David A. Wilcox, Sandra L. Haberichter